HEADER TRANSFERASE/TRANSFERASE INHIBITOR 14-JUL-11 3SX9 TITLE CALCIUM-DEPENDENT PROTEIN KINASE 1 FROM TOXOPLASMA GONDII (TGCDPK1) IN TITLE 2 COMPLEX WITH BUMPED KINASE INHIBITOR, RM-1-132 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CALMODULIN-DOMAIN PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CALMODULIN-DOMAIN PROTEIN KINASE, PUTATIVE; COMPND 5 EC: 2.7.11.17; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TOXOPLASMA GONDII; SOURCE 3 ORGANISM_TAXID: 5811; SOURCE 4 GENE: AAG53993, CDPK1, TGGT1_059880, TGVEG_042030; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: AVA0421 KEYWDS SERINE/THREONINE PROTEIN KINASE, TRANSFERASE, CALCIUM-BINDING, ATP- KEYWDS 2 BINDING, CALMODULIN, EF HAND, BUMPED KINASE INHIBITOR, TRANSFERASE- KEYWDS 3 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.T.LARSON,E.A.MERRITT REVDAT 3 08-NOV-17 3SX9 1 REMARK REVDAT 2 09-JAN-13 3SX9 1 JRNL REVDAT 1 14-MAR-12 3SX9 0 JRNL AUTH E.T.LARSON,K.K.OJO,R.C.MURPHY,S.M.JOHNSON,Z.ZHANG,J.E.KIM, JRNL AUTH 2 D.J.LEIBLY,A.M.FOX,M.C.REID,E.J.DALE,B.G.PERERA,J.KIM, JRNL AUTH 3 S.N.HEWITT,W.G.HOL,C.L.VERLINDE,E.FAN,W.C.VAN VOORHIS, JRNL AUTH 4 D.J.MALY,E.A.MERRITT JRNL TITL MULTIPLE DETERMINANTS FOR SELECTIVE INHIBITION OF JRNL TITL 2 APICOMPLEXAN CALCIUM-DEPENDENT PROTEIN KINASE CDPK1. JRNL REF J.MED.CHEM. V. 55 2803 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22369268 JRNL DOI 10.1021/JM201725V REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.M.JOHNSON,R.C.MURPHY,J.A.GEIGER,A.E.DEROCHER,Z.ZHANG, REMARK 1 AUTH 2 K.K.OJO,E.T.LARSON,B.G.PERERA,E.J.DALE,P.HE,M.C.REID, REMARK 1 AUTH 3 A.M.FOX,N.R.MUELLER,E.A.MERRITT,E.FAN,M.PARSONS, REMARK 1 AUTH 4 W.C.VAN VOORHIS,D.J.MALY REMARK 1 TITL DEVELOPMENT OF TOXOPLASMA GONDII CALCIUM-DEPENDENT PROTEIN REMARK 1 TITL 2 KINASE 1 (TGCDPK1) INHIBITORS WITH POTENT ANTI-TOXOPLASMA REMARK 1 TITL 3 ACTIVITY. REMARK 1 REF J.MED.CHEM. V. 17 602 2012 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 22320388 REMARK 1 DOI 10.1021/JM201713H REMARK 1 REFERENCE 2 REMARK 1 AUTH R.C.MURPHY,K.K.OJO,E.T.LARSON,A.CASTELLANOS-GONZALEZ, REMARK 1 AUTH 2 B.G.PERERA,K.R.KEYLOUN,J.E.KIM,J.G.BHANDARI,N.R.MULLER, REMARK 1 AUTH 3 C.L.VERLINDE,A.C.WHITE,E.A.MERRITT,W.C.VAN VOORHIS,D.J.MALY REMARK 1 TITL DISCOVERY OF POTENT AND SELECTIVE INHIBITORS OF REMARK 1 TITL 2 CALCIUM-DEPENDENT PROTEIN KINASE 1 (CDPK1) FROM C. PARVUM REMARK 1 TITL 3 AND T. GONDII. REMARK 1 REF ACS MED CHEM LETT V. 1 331 2010 REMARK 1 REFN ISSN 1948-5875 REMARK 1 PMID 21116453 REMARK 1 DOI 10.1021/ML100096T REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REFMAC_5.6.0095 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.89 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 13331 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 677 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.64 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.71 REMARK 3 REFLECTION IN BIN (WORKING SET) : 856 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.62 REMARK 3 BIN R VALUE (WORKING SET) : 0.2790 REMARK 3 BIN FREE R VALUE SET COUNT : 35 REMARK 3 BIN FREE R VALUE : 0.3310 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3664 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 26 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.99 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.29000 REMARK 3 B22 (A**2) : -2.11000 REMARK 3 B33 (A**2) : 2.60000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.65000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.357 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.291 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 14.201 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.900 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3793 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2628 ; 0.005 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5101 ; 0.907 ; 1.970 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6398 ; 0.883 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 464 ; 4.320 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 564 ; 0.050 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4134 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 747 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS; U VALUES: REFINED INDIVIDUALLY REMARK 4 REMARK 4 3SX9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-JUL-11. REMARK 100 THE DEPOSITION ID IS D_1000066766. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-JUN-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97945 REMARK 200 MONOCHROMATOR : SIDE SCATTERING BENT CUBE-ROOT I REMARK 200 -BEAM SINGLE CRYSTAL; ASYMMETRIC REMARK 200 CUT 4.965 DEGS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13349 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.14500 REMARK 200 R SYM (I) : 0.14500 REMARK 200 FOR THE DATA SET : 9.8020 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.85700 REMARK 200 R SYM FOR SHELL (I) : 0.85700 REMARK 200 FOR SHELL : 1.506 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 3NYV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26% PEG 3350, 0.275 M AMMONIUM REMARK 280 CITRATE, 5 MM DTT, 2.3 MM RM-1-132; FROZEN IN LN2 AFTER SOAKING REMARK 280 IN MOTHER LIQUOR SUPPLEMENTED WITH 10% ETHYLENE GLYCOL, PH 7.0, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.23750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS THE SAME AS AU REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -5 REMARK 465 PRO A -4 REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 MET A -1 REMARK 465 MET A 0 REMARK 465 ASP A 30 REMARK 465 HIS A 31 REMARK 465 LEU A 32 REMARK 465 HIS A 33 REMARK 465 ALA A 34 REMARK 465 THR A 35 REMARK 465 PRO A 36 REMARK 465 GLY A 37 REMARK 465 MET A 38 REMARK 465 PHE A 39 REMARK 465 VAL A 40 REMARK 465 GLN A 41 REMARK 465 GLU A 314 REMARK 465 GLN A 315 REMARK 465 ILE A 316 REMARK 465 SER A 317 REMARK 465 VAL A 318 REMARK 465 MET A 390 REMARK 465 LYS A 391 REMARK 465 GLY A 392 REMARK 465 GLN A 393 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 185 CD CE NZ REMARK 470 LYS A 187 CG CD CE NZ REMARK 470 ASP A 394 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 62 -14.70 79.56 REMARK 500 ARG A 173 -51.90 73.24 REMARK 500 ASP A 174 36.99 -99.00 REMARK 500 ASP A 188 46.63 -106.59 REMARK 500 LEU A 289 30.32 -95.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BK7 A 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3I79 RELATED DB: PDB REMARK 900 APO FORM OF SAME ENZYME REMARK 900 RELATED ID: 3I7B RELATED DB: PDB REMARK 900 SAME ENZYME IN COMPLEX WITH NM-PP1 REMARK 900 RELATED ID: 3I7C RELATED DB: PDB REMARK 900 SAME ENZYME IN COMPLEX WITH NA-PP2 REMARK 900 RELATED ID: 3N51 RELATED DB: PDB REMARK 900 SAME ENZYME IN COMPLEX WITH RM-1-95 REMARK 900 RELATED ID: 3NYV RELATED DB: PDB REMARK 900 SAME ENZYME IN COMPLEX WITH WHI-P180 REMARK 900 RELATED ID: 3MWU RELATED DB: PDB REMARK 900 HOMOLOG FROM C. PARVUM IN COMPLEX WITH RM-1-95 AND CALCIUM REMARK 900 RELATED ID: 3NCG RELATED DB: PDB REMARK 900 HOMOLOG FROM C. PARVUM IN COMPLEX WITH NM-PP1 AND CALCIUM REMARK 900 RELATED ID: 3SXF RELATED DB: PDB REMARK 900 SAME ENZYME IN COMPLEX WITH RM-1-89 REMARK 900 RELATED ID: 3T3U RELATED DB: PDB REMARK 900 SAME ENZYME IN COMPLEX WITH RM-1-130 REMARK 900 RELATED ID: 3T3V RELATED DB: PDB REMARK 900 SAME ENZYME IN COMPLEX WITH RM-1-87 DBREF 3SX9 A 30 507 UNP Q9BJF5 Q9BJF5_TOXGO 30 507 SEQADV 3SX9 GLY A -5 UNP Q9BJF5 EXPRESSION TAG SEQADV 3SX9 PRO A -4 UNP Q9BJF5 EXPRESSION TAG SEQADV 3SX9 GLY A -3 UNP Q9BJF5 EXPRESSION TAG SEQADV 3SX9 SER A -2 UNP Q9BJF5 EXPRESSION TAG SEQADV 3SX9 MET A -1 UNP Q9BJF5 EXPRESSION TAG SEQADV 3SX9 MET A 0 UNP Q9BJF5 EXPRESSION TAG SEQRES 1 A 484 GLY PRO GLY SER MET MET ASP HIS LEU HIS ALA THR PRO SEQRES 2 A 484 GLY MET PHE VAL GLN HIS SER THR ALA ILE PHE SER ASP SEQRES 3 A 484 ARG TYR LYS GLY GLN ARG VAL LEU GLY LYS GLY SER PHE SEQRES 4 A 484 GLY GLU VAL ILE LEU CYS LYS ASP LYS ILE THR GLY GLN SEQRES 5 A 484 GLU CYS ALA VAL LYS VAL ILE SER LYS ARG GLN VAL LYS SEQRES 6 A 484 GLN LYS THR ASP LYS GLU SER LEU LEU ARG GLU VAL GLN SEQRES 7 A 484 LEU LEU LYS GLN LEU ASP HIS PRO ASN ILE MET LYS LEU SEQRES 8 A 484 TYR GLU PHE PHE GLU ASP LYS GLY TYR PHE TYR LEU VAL SEQRES 9 A 484 GLY GLU VAL TYR THR GLY GLY GLU LEU PHE ASP GLU ILE SEQRES 10 A 484 ILE SER ARG LYS ARG PHE SER GLU VAL ASP ALA ALA ARG SEQRES 11 A 484 ILE ILE ARG GLN VAL LEU SER GLY ILE THR TYR MET HIS SEQRES 12 A 484 LYS ASN LYS ILE VAL HIS ARG ASP LEU LYS PRO GLU ASN SEQRES 13 A 484 LEU LEU LEU GLU SER LYS SER LYS ASP ALA ASN ILE ARG SEQRES 14 A 484 ILE ILE ASP PHE GLY LEU SER THR HIS PHE GLU ALA SER SEQRES 15 A 484 LYS LYS MET LYS ASP LYS ILE GLY THR ALA TYR TYR ILE SEQRES 16 A 484 ALA PRO GLU VAL LEU HIS GLY THR TYR ASP GLU LYS CYS SEQRES 17 A 484 ASP VAL TRP SER THR GLY VAL ILE LEU TYR ILE LEU LEU SEQRES 18 A 484 SER GLY CYS PRO PRO PHE ASN GLY ALA ASN GLU TYR ASP SEQRES 19 A 484 ILE LEU LYS LYS VAL GLU LYS GLY LYS TYR THR PHE GLU SEQRES 20 A 484 LEU PRO GLN TRP LYS LYS VAL SER GLU SER ALA LYS ASP SEQRES 21 A 484 LEU ILE ARG LYS MET LEU THR TYR VAL PRO SER MET ARG SEQRES 22 A 484 ILE SER ALA ARG ASP ALA LEU ASP HIS GLU TRP ILE GLN SEQRES 23 A 484 THR TYR THR LYS GLU GLN ILE SER VAL ASP VAL PRO SER SEQRES 24 A 484 LEU ASP ASN ALA ILE LEU ASN ILE ARG GLN PHE GLN GLY SEQRES 25 A 484 THR GLN LYS LEU ALA GLN ALA ALA LEU LEU TYR MET GLY SEQRES 26 A 484 SER LYS LEU THR SER GLN ASP GLU THR LYS GLU LEU THR SEQRES 27 A 484 ALA ILE PHE HIS LYS MET ASP LYS ASN GLY ASP GLY GLN SEQRES 28 A 484 LEU ASP ARG ALA GLU LEU ILE GLU GLY TYR LYS GLU LEU SEQRES 29 A 484 MET ARG MET LYS GLY GLN ASP ALA SER MET LEU ASP ALA SEQRES 30 A 484 SER ALA VAL GLU HIS GLU VAL ASP GLN VAL LEU ASP ALA SEQRES 31 A 484 VAL ASP PHE ASP LYS ASN GLY TYR ILE GLU TYR SER GLU SEQRES 32 A 484 PHE VAL THR VAL ALA MET ASP ARG LYS THR LEU LEU SER SEQRES 33 A 484 ARG GLU ARG LEU GLU ARG ALA PHE ARG MET PHE ASP SER SEQRES 34 A 484 ASP ASN SER GLY LYS ILE SER SER THR GLU LEU ALA THR SEQRES 35 A 484 ILE PHE GLY VAL SER ASP VAL ASP SER GLU THR TRP LYS SEQRES 36 A 484 SER VAL LEU SER GLU VAL ASP LYS ASN ASN ASP GLY GLU SEQRES 37 A 484 VAL ASP PHE ASP GLU PHE GLN GLN MET LEU LEU LYS LEU SEQRES 38 A 484 CYS GLY ASN HET BK7 A 701 30 HETNAM BK7 3-(6-ETHOXYNAPHTHALEN-2-YL)-1-(PIPERIDIN-4-YLMETHYL)- HETNAM 2 BK7 1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE HETSYN BK7 RM-1-132 FORMUL 2 BK7 C23 H26 N6 O FORMUL 3 HOH *26(H2 O) HELIX 1 1 ILE A 46 ARG A 50 1 5 HELIX 2 2 ASP A 92 LEU A 106 1 15 HELIX 3 3 GLU A 135 SER A 142 1 8 HELIX 4 4 SER A 147 ASN A 168 1 22 HELIX 5 5 LYS A 176 GLU A 178 5 3 HELIX 6 6 LYS A 207 ILE A 212 1 6 HELIX 7 7 GLY A 213 ILE A 218 1 6 HELIX 8 8 ALA A 219 GLY A 225 1 7 HELIX 9 9 GLU A 229 GLY A 246 1 18 HELIX 10 10 ASN A 254 GLY A 265 1 12 HELIX 11 11 LEU A 271 LYS A 275 5 5 HELIX 12 12 SER A 278 LEU A 289 1 12 HELIX 13 13 SER A 298 LEU A 303 1 6 HELIX 14 14 HIS A 305 THR A 312 1 8 HELIX 15 15 LEU A 323 ASP A 368 1 46 HELIX 16 16 ARG A 377 ARG A 389 1 13 HELIX 17 17 ASP A 394 LEU A 398 5 5 HELIX 18 18 ASP A 399 VAL A 414 1 16 HELIX 19 19 TYR A 424 ASP A 451 1 28 HELIX 20 20 SER A 460 SER A 470 1 11 HELIX 21 21 ASP A 473 ASP A 485 1 13 HELIX 22 22 PHE A 494 LEU A 504 1 11 SHEET 1 A 5 TYR A 51 GLY A 60 0 SHEET 2 A 5 GLY A 63 ASP A 70 -1 O LEU A 67 N GLN A 54 SHEET 3 A 5 GLU A 76 SER A 83 -1 O VAL A 81 N GLU A 64 SHEET 4 A 5 TYR A 123 GLU A 129 -1 O LEU A 126 N LYS A 80 SHEET 5 A 5 LEU A 114 GLU A 119 -1 N PHE A 118 O TYR A 125 SHEET 1 B 2 LEU A 180 LEU A 182 0 SHEET 2 B 2 ILE A 191 ILE A 193 -1 O ARG A 192 N LEU A 181 SHEET 1 C 2 GLN A 374 ASP A 376 0 SHEET 2 C 2 TYR A 421 GLU A 423 -1 O ILE A 422 N LEU A 375 SHEET 1 D 2 LYS A 457 SER A 459 0 SHEET 2 D 2 GLU A 491 ASP A 493 -1 O VAL A 492 N ILE A 458 SITE 1 AC1 11 LEU A 57 VAL A 65 ALA A 78 LYS A 80 SITE 2 AC1 11 MET A 112 LEU A 126 GLU A 129 TYR A 131 SITE 3 AC1 11 GLU A 135 ILE A 194 ASP A 195 CRYST1 48.281 72.475 67.267 90.00 103.81 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020712 0.000000 0.005091 0.00000 SCALE2 0.000000 0.013798 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015309 0.00000 MASTER 348 0 1 22 11 0 3 6 0 0 0 38 END